Key Takeaways
- Lumentum reached an unprecedented peak of $808.80 Thursday before settling at $777.17
- The optical component maker’s inclusion in the S&P 500 triggered substantial index fund purchases
- Wall Street analysts boosted price targets significantly, with increases reaching as high as 66%
- Second-quarter results exceeded expectations with EPS of $1.67 versus forecasted $1.41, while revenue jumped 65.5% annually
- The firm revealed plans for a 240,000 square foot North Carolina manufacturing site producing AI datacenter lasers, counting Nvidia among its clients
Lumentum (LITE) shares touched a record high of $808.80 during Thursday’s session before retreating to finish at $777.17. In premarket trading on March 26, shares declined 3.49% to $750.
The optical technology provider’s remarkable ascent stems from multiple catalysts: bullish Wall Street sentiment, benchmark index addition, impressive quarterly performance, and a significant expansion announcement.
The company unveiled its intention to establish a cutting-edge laser production facility in Greensboro, North Carolina. This 240,000 square foot property, purchased from semiconductor manufacturer Qorvo (QRVO), will focus on manufacturing InP-based optical solutions, spanning continuous wave technology and ultra-high-power laser systems.
Nvidia (NVDA) has been confirmed as a client for this facility. Manufacturing operations are slated to begin scaling in mid-2028.
Lumentum disclosed plans to allocate hundreds of millions of dollars to the location over coming years. The expansion is projected to maintain and generate more than 400 American manufacturing positions.
CEO Michael Hurlston commented: “Our customers are building the infrastructure that will define the next era of computing. Adding this new InP manufacturing facility significantly expands our capacity, deepens our strategic partnerships, and ensures we can deliver the performance, reliability, and scale required for the AI revolution.”
Wall Street Optimism and Index Addition
A succession of analyst target price elevations contributed momentum to LITE’s climb. B. Riley shifted its stance from neutral to buy while increasing its price objective from $147 to $526. JPMorgan established a $565 target with an overweight recommendation. Citigroup assigned a $560 target with a buy rating. UBS elevated its forecast from $215 to $455 while maintaining a neutral stance. Morgan Stanley increased its projection to $595 but retained an equal weight designation.
The consensus analyst price target currently stands at $575.06, supported by two strong buy recommendations, eleven buy ratings, and six hold ratings.
Lumentum secured admission to the S&P 500 recently, a development that conventionally generates automated purchases from passive index funds and exchange-traded funds. This systematic capital inflow likely contributed additional momentum to the stock’s advance.
Quarterly Performance and Valuation Concerns
During its latest reporting period, Lumentum delivered earnings per share of $1.67, surpassing the consensus forecast of $1.41. Revenue totaled $665.50 million, representing a 65.5% year-over-year increase and exceeding the $646.74 million estimate. Management established Q3 2026 EPS guidance in the range of $2.15–$2.35.
However, several factors warrant consideration. The stock commands a P/E ratio of 238, representing a premium valuation by virtually any standard. Corporate insiders have been reducing holdings — CFO Wajid Ali divested 5,302 shares in late February at an average price of $691.13, while insiders collectively sold 65,775 shares during the previous 90 days.
Institutional ownership comprises 94.05% of outstanding shares. Vanguard, Arrowstreet Capital, and Geode Capital have all expanded their stakes in recent periods.
The 50-day moving average rests at $567.66, while the 200-day average sits at $363.11 — both substantially below current price levels.
